Status:
UNKNOWN
Adjunctive Effect of Acupuncture for Advanced Cancer Patients With Palliative Care: a Three-arm Randomized Trial
Lead Sponsor:
The University of Hong Kong
Conditions:
Advanced Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The proposed study aims to evaluate the adjunctive effect of MA with standard care (ASC) for relieving cancer-related symptoms in a collaborative model of palliative care compared to sham MA plus stan...
Detailed Description
After being informed about the study plan, potential risk and benefits, all subjects will give written informed consent prior to participation and undergo eligibility screening. Eligible participants ...
Eligibility Criteria
Inclusion
- All cases are subject to pathology and (or) cytology for a diagnosis of malignant tumour (pathological type is not restricted) at stage IIIB or IV;
- Aged 18 years or above;
- Expected survival time longer than 16 weeks;
Exclusion
- Disseminated intravascular coagulation or severe thrombocytopenia with a bleeding tendency, i.e., low platelet count \< 35000/µL; INR \> 1.5; hemoglobin ≤ 90 g/dL; white blood cell count ≤ 4x109/L;
- Uncontrolled active skin infection;
- Needle phobia;
- Inability to read and understand Chinese;
- Not signed written informed consent.
- Receiving surgery during the whole study period;
- Receiving acupuncture treatment in the last 3 months
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04398875
Start Date
September 1 2020
End Date
August 31 2023
Last Update
May 21 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.